Citation tools
"Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study." Journal of Nuclear Medicine
62.8
(2021):
1050-1056.
Web. 03 May. 2025.